title: [Current status of Helicobacter pylori eradication therapy. Significance of roxithromycin].
authors.affiliation: Internistische Praxis mit gastroenterologischem Schwerpunkt, Frankfurt/Main.
authors.forename: H
authors.initials: H
authors.lastname: Bock
authors.forename: A
authors.initials: A
authors.lastname: Mares
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000188:drug therapy*; D015575:Roxithromycin / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D015575:Roxithromycin